Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T KING

Showing results (871-880 of 1,347) with videos related to

Pageof 135
Sort By:
ACS Applied Materials & Interfaces|May 10, 2023
Two-Dimensional Siloxene Nanosheets: Impact of Morphology and Purity on ElectrochemistryJessica Luo, David J Arnot, Steven T King, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Brachytherapy|March 25, 2016
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapyMartin T King, Nicola J Nasser, Nitin Mathur, et al.
Nature Biotechnology|June 1, 2001
Deletion of the alpha(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheepC Denning, S Burl, A Ainslie, et al.
Respiratory Medicine|August 24, 2024
Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registryElizabeth M Webb, Anne E Holland, Anne B Chang, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the NetherlandsMicha J Pilz, Simon Seyringer, Lára R Hallsson, et al.
EJNMMI Radiopharmacy and Chemistry|June 26, 2026
Easy and versatile preparation of <sup>68</sup>Ga- and Al<sup>18</sup>F-labelled arylphosphonium salts from a common precursor: stability and preliminary in vivo PET/CT evaluationJoseph A Ioppolo, Leila R Hill, Alexander W E Sadler, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
Brachytherapy|August 22, 2025
Intraoperative low-dose rate brachytherapy as an adjunct to surgery for marginally resectable rectal and recurrent anorectal carcinomasMustafa M Al Balushi, Teresia M Perkins, Kee-Young Shin, et al.
Pageof 135

Showing results (871-880 of 1,347) with videos related to

Sort By:
Pageof 135
ACS Applied Materials & Interfaces|May 10, 2023
Two-Dimensional Siloxene Nanosheets: Impact of Morphology and Purity on ElectrochemistryJessica Luo, David J Arnot, Steven T King, et al.
JNCI Cancer Spectrum|April 25, 2020
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast CancerJammbe Z Musoro, Corneel Coens, Frederic Fiteni, et al.
Brachytherapy|March 25, 2016
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapyMartin T King, Nicola J Nasser, Nitin Mathur, et al.
Nature Biotechnology|June 1, 2001
Deletion of the alpha(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheepC Denning, S Burl, A Ainslie, et al.
Respiratory Medicine|August 24, 2024
Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registryElizabeth M Webb, Anne E Holland, Anne B Chang, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 14, 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the NetherlandsMicha J Pilz, Simon Seyringer, Lára R Hallsson, et al.
EJNMMI Radiopharmacy and Chemistry|June 26, 2026
Easy and versatile preparation of <sup>68</sup>Ga- and Al<sup>18</sup>F-labelled arylphosphonium salts from a common precursor: stability and preliminary in vivo PET/CT evaluationJoseph A Ioppolo, Leila R Hill, Alexander W E Sadler, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
Brachytherapy|August 22, 2025
Intraoperative low-dose rate brachytherapy as an adjunct to surgery for marginally resectable rectal and recurrent anorectal carcinomasMustafa M Al Balushi, Teresia M Perkins, Kee-Young Shin, et al.
Pageof 135